DermTech exploring strategic alternatives, cutting 56% of staff

seekingalpha04-19

DermTech (NASDAQ:DMTK) said its board has engaged TD Cowen to explore strategic alternatives for the company and that it plans to cut approximately 56% of its workforce to conserve cash. The genomics ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2428405205?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1500584309/image_1500584309.jpg","is_english":true,"pubTime":"2024-04-19 04:54","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2428405205","market":"sg","top_or_hot":-1,"title":"DermTech exploring strategic alternatives, cutting 56% of staff","media":"seekingalpha","content":"<div>\n<p>DermTech (NASDAQ:DMTK) said its board has engaged TD Cowen to explore strategic alternatives for the company and that it plans to cut approximately 56% of its workforce to conserve cash. The genomics ...</p>\n\n<a href=\"https://seekingalpha.com/news/4091302-dermtech-exploring-strategic-alternatives-cutting-56-percent-of-staff\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DermTech exploring strategic alternatives, cutting 56% of staff</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDermTech exploring strategic alternatives, cutting 56% of staff\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-19 04:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4091302-dermtech-exploring-strategic-alternatives-cutting-56-percent-of-staff><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DermTech (NASDAQ:DMTK) said its board has engaged TD Cowen to explore strategic alternatives for the company and that it plans to cut approximately 56% of its workforce to conserve cash. The genomics ...</p>\n\n<a href=\"https://seekingalpha.com/news/4091302-dermtech-exploring-strategic-alternatives-cutting-56-percent-of-staff\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://seekingalpha.com/news/4091302-dermtech-exploring-strategic-alternatives-cutting-56-percent-of-staff","article_id":"2428405205","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1500584309/image_1500584309.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2428405205","pubTimestamp":1713473680,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"DermTech (NASDAQ:DMTK) said its board has engaged TD Cowen to explore strategic alternatives for the company and that it plans to cut approximately 56% of its workforce to conserve cash. The genomics ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技"},"translate_title":"DermTech探索战略替代方案，裁员56%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DMTK":1},"content_text":"DermTech (NASDAQ:DMTK) said its board has engaged TD Cowen to explore strategic alternatives for the company and that it plans to cut approximately 56% of its workforce to conserve cash. The genomics dermatology company said that TD Cowen will be conducting a review of strategic options for the company, including a possible merger, acquisition or asset sale. As a result of the review, the company will not be hosting a Q1 earnings conference call. DermTech also plans to lay off around 100 employees, or about 56% of its workforce. The company plans to continue its laboratory operations during the strategic review and believes it has enough capacity to process orders for its DermTech melanoma test.  As a result of the restructuring, DermTech expects to take a one-time charge of approximately $1.6M in Q2. The layoffs are part of the latest round of restructuring for DermTech. The company announced it was cutting 15% of its workforce and suspending development on its pipeline in June 2023 to focus on its melanoma test. It announced another 15% workforce reduction in January.  More on DermTech  DermTech, Inc. (DMTK) Q4 2023 Earnings Call Transcript DermTech GAAP EPS of -$0.56 in-line, revenue of $3.92M misses by $0.11M DermTech Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on DermTech Historical earnings data for DermTech","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428405205"}